Trump Secures Deal to Lower Prices of Weight Loss Drugs
President Trump has announced a significant agreement with drug manufacturers Novo Nordisk and Eli Lilly to reduce the prices of GLP-1 weight loss medications, Wegovy and Zepbound. This initiative aims to improve accessibility for millions struggling with obesity, potentially enhancing health outcomes and quality of life. The deal is seen as a proactive step towards addressing rising healthcare costs and improving public health.
Trump Secures Deal to Lower Prices of Weight Loss Drugs
President Trump has announced a significant agreement with drug manufacturers Novo Nordisk and Eli Lilly to reduce the prices of GLP-1 weight loss medications, Wegovy and Zepbound. This initiative aims to improve accessibility for millions struggling with obesity, potentially enhancing health outcomes and quality of life. The deal is seen as a proactive step towards addressing rising healthcare costs and improving public health.
Why World Pulse Now
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Stories
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Multi-Language
Switch languages to read your way
Save for Later
Your stories, stored for later
Live Stats
Our system has analyzed 7,702 articles worldwide
~320 per hour
654 trending stories shaping headlines
From breaking news to viral moments
Monitoring 362 trusted sources
Major outlets & specialized publications
Latest update 6 days ago
Always fresh
Latest Apps and Tools
Discover what founders, creators, and innovators are building next